Haemonetics Corp (HAE) - Product Pipeline Analysis, 2018 Update

Haemonetics Corp (HAE) - Product Pipeline Analysis, 2018 Update

  • Products Id :- GDME707PD
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary


Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite of solutions to the blood supply chain, which ranges from plasma and blood collectors to hospitals. Haemonetics markets its products to blood collection groups and independent blood centers, national health organizations, hospital service providers, hospitals, group purchasing organizations, and bio-pharmaceutical companies through a direct sales force and independent distributors. It has subsidiaries in the Americas, Asia and Europe. Haemonetics is headquartered in Braintree, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Haemonetics Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Haemonetics Corp Company Overview 4

Haemonetics Corp Company Snapshot 4

Haemonetics Corp Pipeline Products and Ongoing Clinical Trials Overview 4

Haemonetics Corp-Pipeline Analysis Overview 6

Business Description 6

Haemonetics Corp-Key Facts 6

Haemonetics Corp-Major Products and Services 7

Haemonetics Corp Pipeline Products by Development Stage 10

Haemonetics Corp Pipeline Products Overview 12

Automated Whole Blood Collection System 12

Automated Whole Blood Collection System Product Overview 12

Blood Typing System 13

Blood Typing System Product Overview 13

Donor Doc 1.5 14

Donor Doc 1.5 Product Overview 14

Plasma Device 15

Plasma Device Product Overview 15

RCS Filter 16

RCS Filter Product Overview 16

SOLX Whole Blood Collection System-24 Hours 17

SOLX Whole Blood Collection System-24 Hours Product Overview 17

Haemonetics Corp-Key Competitors 18

Haemonetics Corp-Key Employees 19

Haemonetics Corp-Key Employee Biographies 20

Haemonetics Corp-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 24

Haemonetics Corp, Recent Developments 24

May 08, 2018: Haemonetics Reports 4th Quarter and Fiscal Year 2018 Results and Provides Fiscal 2019 Guidance 24

May 08, 2018: Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer 25

Mar 28, 2018: Haemonetics Announces Regulatory Clearances of NexSys PCS Enhanced Software with YES Technology 25

Feb 06, 2018: Haemonetics 3rd Quarter Fiscal 2018 Earnings 26

Jan 25, 2018: Ellen M. Zane Rejoins Haemonetics Board of Directors 27

Oct 18, 2017: Robert E. Abernathy Joins Haemonetics Board of Directors 28

Sep 14, 2017: Haemonetics Appoints David J. Wilson Plasma Business Unit President 28

Jul 28, 2017: Haemonetics Announces FDA Clearance of New Plasmapheresis System Branded NexSys PCS 28

Jun 22, 2017: Haemonetics Announces Formation of Scientific Advisory Council 29

May 08, 2017: Haemonetics Reports 4th Quarter and Fiscal Year 2017 Results and Provides Fiscal 2018 Guidance 29

Appendix 31

Methodology 31

About GlobalData 34

Contact Us 34

Disclaimer 34

List of Figures

Haemonetics Corp Pipeline Products by Equipment Type 5

Haemonetics Corp Pipeline Products by Development Stage 10

List of Tables

Haemonetics Corp Pipeline Products and Ongoing Clinical Trials Overview 4

Haemonetics Corp Pipeline Products by Equipment Type 5

Haemonetics Corp, Key Facts 6

Haemonetics Corp, Major Products and Services 7

Haemonetics Corp Number of Pipeline Products by Development Stage 10

Haemonetics Corp Pipeline Products Summary by Development Stage 11

Automated Whole Blood Collection System-Product Status 12

Automated Whole Blood Collection System-Product Description 12

Blood Typing System-Product Status 13

Blood Typing System-Product Description 13

Donor Doc 1.5-Product Status 14

Donor Doc 1.5-Product Description 14

Plasma Device-Product Status 15

Plasma Device-Product Description 15

RCS Filter-Product Status 16

RCS Filter-Product Description 16

SOLX Whole Blood Collection System-24 Hours-Product Status 17

SOLX Whole Blood Collection System-24 Hours-Product Description 17

Haemonetics Corp, Key Employees 19

Haemonetics Corp, Key Employee Biographies 20

Haemonetics Corp, Other Locations 21

Haemonetics Corp, Subsidiaries 22

Glossary 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Terumo BCT Inc


Medtronic Plc

MAK Technologies

LivaNova PLC

Hamilton Thorne Ltd

Fresenius Medical Care AG & Co KGaA

Haemonetics Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53228
Site License
USD 1500 INR 106455
Corporate User License
USD 2250 INR 159683



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com